Literature DB >> 13228713

Insulin coma therapy in schizophrenia; a fourteen-year follow-up study.

F H WEST, E D BOND, J T SHURLEY, C D MEYERS.   

Abstract

Entities:  

Keywords:  SCHIZOPHRENIA/therapy; SHOCK THERAPY, INSULIN

Mesh：

Substances：

Year:  1955        PMID： 13228713     DOI： 10.1176/ajp.111.8.583

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  The effect of insulin coma and E.C.T. on the short-term prognosis of schizophrenia.

Authors:  J HOENIG; D M LEIBERMAN; I AUERBACH
Journal:  J Neurol Neurosurg Psychiatry       Date:  1956-05       Impact factor: 10.154

2.  Interdisciplinary treatment planning in inpatient settings: from myth to model.

Authors:  Kris A McLoughlin; Jeffrey L Geller
Journal:  Psychiatr Q       Date:  2010-09

3.  A history of private psychiatric hospitals in the USA: from start to almost finished.

Authors:  Jeffrey L Geller
Journal:  Psychiatr Q       Date:  2006

4.  Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia.

Authors:  Fernando Caravaggio; Margaret Hahn; Shinichiro Nakajima; Philip Gerretsen; Gary Remington; Ariel Graff-Guerrero
Journal:  Med Hypotheses       Date:  2015-06-24       Impact factor: 1.538

5.  Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans.

Authors:  Fernando Caravaggio; Carol Borlido; Margaret Hahn; Zhe Feng; Gagan Fervaha; Philip Gerretsen; Shinichiro Nakajima; Eric Plitman; Jun Ku Chung; Yusuke Iwata; Alan Wilson; Gary Remington; Ariel Graff-Guerrero
Journal:  Int J Neuropsychopharmacol       Date:  2015-02-25       Impact factor: 5.176

6.  'A landmark in psychiatric progress'? The role of evidence in the rise and fall of insulin coma therapy.

Authors:  Robert Freudenthal; Joanna Moncrieff
Journal:  Hist Psychiatry       Date:  2021-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.